CRVS (Corvus Pharmaceuticals) Machinery, Furniture, Equipment : $0.19 Mil (As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Corvus Pharmaceuticals Machinery, Furniture, Equipment?

Corvus Pharmaceuticals's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2025 was $0.19 Mil.

Corvus Pharmaceuticals's quarterly Machinery, Furniture, Equipment stayed the same from Sep. 2024 ($0.17 Mil) to Dec. 2024 ($0.17 Mil) but then increased from Dec. 2024 ($0.17 Mil) to Mar. 2025 ($0.19 Mil).

Corvus Pharmaceuticals's annual Machinery, Furniture, Equipment increased from Dec. 2022 ($0.14 Mil) to Dec. 2023 ($0.17 Mil) but then stayed the same from Dec. 2023 ($0.17 Mil) to Dec. 2024 ($0.17 Mil).

Corvus Pharmaceuticals Machinery, Furniture, Equipment Historical Data

The historical data trend for Corvus Pharmaceuticals's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corvus Pharmaceuticals Machinery, Furniture, Equipment Chart

Corvus Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Machinery, Furniture, Equipment

Get a 7-Day Free Trial

0.14

0.17

Corvus Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Machinery, Furniture, Equipment	Get a 7-Day Free Trial															0.17	0.17	0.17	0.17	0.19

Corvus Pharmaceuticals Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.

Corvus Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corvus Pharmaceuticals Inc (NAS:CRVS) » Definitions » Machinery, Furniture, Equipment

Comparable Companies

Traded in Other Exchanges

N/A

Address

901 Gateway Boulevard, Third Floor, South San Francisco, CA, USA, 94080

Website

https://www.corvuspharma.com

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Executives

William Benton Jones	officer: See Remarks	863 MITTEN ROAD, SUITE 102, BURLINGAME CA 94010
Miller Richard A Md	director, officer: President and CEO	PHARMACYCLICS INC, 995 E ARQUES AVE, SUNNYVALE CA 94085-4521
Linda S Grais	director	86 ALEJANDRA AVE, ATHERTON CA 94027
Leiv Lea	officer: Chief Financial Officer	PHARMACYCLICS INC, 995 E ARQUES AVE, SUNNYVALE CA 94085-4521
Ecor1 Capital, Llc	10 percent owner	357 TEHAMA STREET #3, SAN FRANCISCO CA 94103
Peter A. Thompson	director, 10 percent owner	C/O ANTHERA PHARMACEUTICALS, INC., 25801 INDUSTRIAL BOULEVARD, SUITE B, HAYWARD CA 94545
Orbimed Advisors Llc	director	601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK NY 10022
Edith P. Mitchell	director	1640 MARENGO ST., LOS ANGELES CA 90033
Novo Holdings A/s	10 percent owner	TUBORG HAVNEVEJ 19, HELLERUP G7 2900
Mehrdad Mobasher	officer: Chief Medical Officer	863 MITTEN ROAD, BURLINGAME CA 94010
Adams Street Partners Llc	10 percent owner	ONE NORTH WACKER DRIVE, STE 2700, CHICAGO IL 60606-2807
Terry P Gould	director, 10 percent owner	C/O ONCOMED PHARMACEUTICALS, INC., 800 CHESAPEAKE DRIVE, REDWOOD CITY CA 94063
Joseph J Buggy	officer: EVP Discovery Research	CORVUS PHARMACEUTICALS, INC., 863 MITTEN ROAD, SUITE 102, BURLINGAME CA 94010
Daniel W. Hunt	officer: SVP, Chief Business Officer	863 MITTEN ROAD, SUITE 102, BURLINGAME CA 94010
Erik J. Verner	officer: V.P., Chemistry Research	863 MITTEN ROAD, SUITE 102, BURLINGAME CA 94010